Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis

Author(s):
Mease, P.J.; Gottlieb, A.B.; Heijde, D. van der; FitzGerald, O.; Johnsen, A.; Nys, M.; Banerjee, S.; Gladman, D.D.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-09-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2017), Vol. 76, no. 9, p. 1550-1558
hdl
1887/116170
doi
10.1136/annrheumdis-2016-210724